Form 8-K - Current report:
SEC Accession No. 0000899923-20-000006
Filing Date
2020-12-07
Accepted
2020-12-07 17:02:18
Documents
15
Period of Report
2020-12-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20201204.htm   iXBRL 8-K 70189
2 EX-10.1 exhibit1012017employee.htm EX-10.1 84162
  Complete submission text file 0000899923-20-000006.txt   315141

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20201204.xsd EX-101.SCH 2405
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20201204_cal.xml EX-101.CAL 698
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20201204_def.xml EX-101.DEF 1631
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20201204_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20201204_pre.xml EX-101.PRE 12634
8 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20201204_htm.xml XML 10755
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 201373332
SIC: 2835 In Vitro & In Vivo Diagnostic Substances